August 2010 FDA Guidances

:Original raster version: :Image:Food and Drug...
Image via Wikipedia

Each month, Cato Research Regulatory Scientist Cathy Anderson compiles a list of the notable guidance documents released by the FDA.  Here’s a summary of the guidances released in August 2010 (links go directly to PDF documents).

Special Interest Guidances/Information

Date Posted
General Considerations for Animal Studies for Cardiovascular Devices 07/29/2010

Other Recent Guidances

Date Posted
Q4B: Pharmacopoeial Texts for Use in the ICH Regions:

09/2/2010
Acute Bacterial Skin and Skin Structure Infections: Developing Drugs for Treatment (Draft) 08/26/2010
Organ-Specific Warnings: Internal Analgesic, Antipyretic, and Antirheumatic Drug Products for Over-the-Counter Human Use – Small Entity Compliance 8/17/2010
Label Comprehension Studies for Nonprescription Drug Products 08/3/2010
Guidance for the Non‐Clinical and Clinical Investigation of Devices Used for the Treatment of Benign Prostatic Hyperplasia (BPH) 08/17/2010
Contact Lens Care Products Labeling 08/15/2010
Recommendations for Premarket Notifications for Lamotrigine and Zonisamide Assays (Draft) 08/06/2010

This entry was posted in FDA, Industry News. Bookmark the permalink.

Comments are closed.